$CMPX
Compass Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.891
▼-1.14%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCompass Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CMPX down today? It is at $0.891 (-1.14%), and our scanner flagged it 161 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CMPX spikes, and full due diligence on CMPX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CMPX 161 times in the last 30 days. Create a free account to track $CMPX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CMPX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CMPX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Oct 2, 2026 · 2 days ago* Institutional ownership was unavailable, so float is insider-deduped only.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lerner Neil Officer | Bought (open market) | +20K 0.01% of company | added 5.0% | 420K | $18K at $0.920 | Oct 1, 26 |
Lerner Neil Officer | Bought (open market) | +3K | added 0.6% | 400K | $3K at $1.14 | Sep 24, 26 |
Lerner Neil Officer | Acquired (grant/award) | +15K | added 3.9% | 398K | $28K at $1.89 | Apr 29, 26 |
Anderman Jonathan Officer | Acquired (grant/award) | +25K 0.01% of company | added 15% | 196K | $47K at $1.89 | Apr 29, 26 |
Schuetz Thomas J. Officer | Sold (automatic/other) | -37K 0.02% of company | sold 0.6% | 6.60M | $239K at $6.52 | Feb 8, 26 |
Schuetz Thomas J. Officer | Sold (automatic/other) | -47K 0.03% of company | sold 0.7% | 6.64M | $250K at $5.35 | Jan 9, 26 |
Anderman Jonathan Officer | Acquired (grant/award) | +150K 0.08% of company | added 100% | 171K | $776K at $5.17 | Jan 2, 26 |
Lerner Neil Officer | Acquired (grant/award) | +63K 0.03% of company | added 20% | 383K | $323K at $5.17 | Jan 2, 26 |
Schuetz Thomas J. Officer | Acquired (grant/award) | +250K 0.1% of company | added 3.9% | 6.69M | $1.3M at $5.17 | Jan 2, 26 |
Shin Barry Officer | Acquired (grant/award) | +125K 0.07% of company | added 31% | 525K | $646K at $5.17 | Jan 2, 26 |
Schuetz Thomas J. Officer | Sold (automatic/other) | -44K 0.02% of company | sold 0.7% | 6.44M | $213K at $4.83 | Nov 16, 25 |
Schuetz Thomas J. Officer | Bought (open market) | +10K | added 0.2% | 6.48M | $21K at $2.11 | May 27, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CMPX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CMPX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CMPX last traded at $0.891, down 1.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Compass Therapeutics, Inc. Common Stock (CMPX) is next expected to report earnings on Wednesday, November 4, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CMPX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CMPX 161 times in the last 30 days.
CMPX (Compass Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $154M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CMPX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CMPX discussion
Sign in to ask a question or join the discussion.